Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed

Xiaoxia Ren

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4079-2789; OpenAlex author ID A5091550310. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2016: 2 papers · 2017: 2 papers

Papers 4

  1. Pancreatic Cancer Progression Relies upon Mutant p53-Induced Oncogenic Signaling Mediated by NOP14. Co-author DOI 10.1158/0008-5472.can-16-2339↗
  2. Molecular Subtyping of Pancreatic Cancer: Translating Genomics and Transcriptomics into the Clinic. Co-author DOI 10.7150/jca.17622↗
  3. Activator protein 1 promotes gemcitabine-induced apoptosis in pancreatic cancer by upregulating its downstream target Bim. Co-author DOI 10.3892/ol.2016.5294↗
  4. c-Fos/ERK promotes the progression from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma. First author DOI 10.3892/or.2016.5169↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yongxing Du · 4 shared papers, 2016–2017 · strength 0.27
  2. Yupei Zhao · 4 shared papers, 2016–2017 · strength 0.27
  3. Lei You · 4 shared papers, 2016–2017 · strength 0.27
  4. Ziwen Liu · 2 shared papers, 2017 · strength 0.14
  5. Bangbo Zhao · 1 shared paper, 2017 · strength 0.07
  6. Taiping Zhang · 1 shared paper, 2016 · strength 0.07
  7. Ming Cui · 1 shared paper, 2016 · strength 0.07
  8. Ge Chen · 1 shared paper, 2016 · strength 0.07
  9. Hong Shu · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.